Skip to content

VerSys® 7841-12-30

by Zimmer, Inc.

VerSys 7841-12-30 is a device of GMDN type press-fit femoral stem prosthesis (FDA Class II; FDA product code LPH, Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented) made by Zimmer, Inc., cleared under FDA 510(k) K953337 on 22 Jan 1996 and listed in FDA GUDID since 24 Nov 2017 (UDI-DI 00889024136069), active as of 23 Oct 2026. 14 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

15 closed

Documents

510(k) K953337

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00889024136069 UDI-DI Date24 Nov 2017ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK953337 Date22 Jan 1996DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K953337 decided 22 Jan 1996 Active
  • FDA GUDID UDI-DI 00889024136069 listed 24 Nov 2017 Listed

Recalls

15 recalls · FDA

    • Terminated Z-0722-2018 FDA Class II initiated 1 Aug 2017

    The products being recalled exceeded the weight previously tested leading to a possibility of damage to the package and/or a compromised sterile barrier.

  • 5 recalls, same reason

    • Terminated Z-2580-2017 FDA Class II initiated 28 Feb 2017
    • Terminated Z-2578-2017 FDA Class II initiated 28 Feb 2017
    • Terminated Z-2581-2017 FDA Class II initiated 28 Feb 2017
    • Terminated Z-2579-2017 FDA Class II initiated 28 Feb 2017
    • Terminated Z-2577-2017 FDA Class II initiated 28 Feb 2017

    Zimmer Biomet Inc. initiated a field action on 02/28/2017 for sterile-packaged implants packaged in two different package configurations due to packaging design verification test failures.

    • Terminated Z-1127-2016 FDA Class II initiated 11 Jan 2016

    As a result of the insufficient sealer calibration data for product packaged in firm's Building II between August 2010 and April 2013. The affected products are sterile.

    • Terminated Z-0849-2016 FDA Class II initiated 11 Jan 2016

    LDPE bag containing the implant adheres to the highly polished implant surface.

  • 2 recalls, same reason

    • Terminated Z-1034-2014 FDA Class II initiated 11 Oct 2013
    • Terminated Z-1031-2014 FDA Class II initiated 11 Oct 2013

    Zimmer recently conducted a review of all historic packaging validations at its Zimmer Manufacturing B.V. (ZMBV) facility in Ponce, Puerto Rico. Based on this review, it was determined that the packaging operations conducted in the Building 1 packaging operation at this facility were not properly validated. As a result, Zimmer conducted seal integrity testing to evaluate if previously packaged product from this facility met the established requirements for sterile barrier integrity. The acceptance criteria established for this testing was 99% reliability with a 90% confidence interval. These packaging tray configurations met the acceptance criteria for sterile barrier integrity of both the inner and outer trays, however, Zimmer has decided to recall all manufacturing lots that have not expired and that were sterile packaged in the ZMBV facility Building 1 packaging operations.

    • Terminated Z-0070-2014 FDA Class II initiated 30 Aug 2013

    The low density polyethylene (LDPE) bag used to package implants adheres to the highly polished surface of the devices.

  • 2 recalls, same reason

    • Terminated Z-2290-2010 FDA Unclassified (pre-2012) initiated 5 Jul 2010
    • Terminated Z-2291-2010 FDA Unclassified (pre-2012) initiated 5 Jul 2010

    Zimmer, Inc. has determined that there is a potential for a package to be labeled as a 28 mm femoral head but contain a 32 mm femoral head. In addition, there is a potential for the patient record label to be incorrect.

    • Terminated Z-0198-2010 FDA Unclassified (pre-2012) initiated 3 Aug 2009

    Manufacturing material may be present on the surface of the implant.

    • Terminated Z-1066-05 FDA Unclassified (pre-2012) initiated 15 Apr 2005 on shared 510(k) K953337

    May be mislabeled as to dimensions; may be 12/14 taper, 28mm dia., neck length +3.5mm.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

17 dated events

  1. Recall initiated FDA recalls Z-1031-2014
  2. Recall initiated FDA recalls Z-1127-2016
  3. Recall initiated FDA recalls Z-0849-2016
  4. Recall initiated FDA recalls Z-2580-2017
  5. Recall initiated FDA recalls Z-2578-2017
  6. Recall initiated FDA recalls Z-2581-2017
  7. Recall initiated FDA recalls Z-2579-2017
  8. Recall initiated FDA recalls Z-2577-2017
  9. Recall initiated FDA recalls Z-0722-2018
  10. Listed FDA GUDID 00889024136069

7 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
VerSys®
Generic name
Press-fit femoral stem prosthesis
Model / reference
7841-12-30
Primary DI / UDI-DI
00889024136069
510(k) Number
FDA product code
LPH
GMDN term
Press-fit femoral stem prosthesis
Device class
Class II
Regulation number
888.3358
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code LPH (PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/POLYMER, POROUS UNCEMENTED).

Other devices from Zimmer, Inc.

See all devices from Zimmer, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)